127
Views
25
CrossRef citations to date
0
Altmetric
Research Article

AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation

, , , , , & show all
Pages 265-272 | Published online: 01 Jul 2009

REFERENCES

  • Erickson, P., Gao, J., et al. (1992) "Identification ofbreakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmen-tation gene, runt", Blood, 80(7), 1825–1831.
  • Downing, JR., Head, D.R., et al. (1993) "An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21) (q22;q22) translocation", Blood, 81(11), 2860— 2865.
  • Lutterbach, B., Westendorf, J.J., et al. (1998) "ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors", Mol. Cell Biol., 18(12), 7176–7184.
  • Wang, J., Hoshino, T., et al. (1998) "ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 com-plex", Proc. Nail. Acad. Sci. USA, 95(18), 10860–10865.
  • Amann, J.M., Nip, J., et al. (2001) "ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomer-ization domain", Mol. Cell Biol., 21(19), 6470— 6483.
  • Klampfer, L., Zhang, J., et al. (1996) "The AML1/ETO fusion protein activates transcription of BCL-2", Proc. Natl. Acad. Sci. USA, 93(24), 14059–14064.
  • Frank, R.C., Sun, X., et al. (1999) "The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1", Oncogene, 18(9), 1701–1710.
  • Okuda, T., Cai, Z., et al. (1998) "Expression of a knocked-in A1\IL1 -ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors", Blood, 91(9), 3134 — 3143.
  • Higuchi, M., O'Brien, D., et al. (2002) "Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia", Cancer Cell, 1(1), 63–74.
  • Mulloy, J.C., Cammenga, J., et al. (2003) "Maintaining the self-renewal and differentiation potential of human CD34 + hematopoietic cells using a single genetic element", Blood, 102(13), 4369–4376.
  • de Guzman, C.G., Warren, A.J., et al. (2002) "Hematopoie-tic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation", Mol. Cell Biol., 22(15), 5506–5517.
  • Schwieger, M., Lohler, J., et al. (2002) "AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency", J. Exp. Med., 196(9), 1227–1240.
  • Yuan, Y., Zhou, L., et al. (2001) "AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations", Proc. Nail. Acad. Sci. USA, 98(18), 10398–10403.
  • Schmidt, M., Nagel, J., et al. (1998) "Lack of interferon consensus binding protein (ICSBP) transcripts in human myeloid leukemia", Blood, 91, 22–29.
  • Basecke, J., Cepek, L., et al. (2002) "Transcription of AML1/ ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia", Blood, 100(6), 2267–2268.
  • Mori, H., Colman, S.M., et al. (2002) "Chromosome translocations and covert leukemic clones are generated during normal fetal development", Proc. Natl. Acad. Sci. USA, 99(12), 8242–8247.
  • Mulloy, J.C., Cammenga, J., et al. (2002) "The AML1-ETO fusion protein promotes the expansion of human hemato-poietic stem cells", Blood, 99(1), 15–23.
  • Tonks, A., Pearn, L., et al. (2003) "The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells", Blood, 101(2), 624 — 632.
  • Bonnet, D. and Dick, J. (1997) "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell", Nat. Med., 3, 730— 737.
  • Baum, C., Hegewisch-Becker, S., et al. (1995) "Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells", 3. Virol., 69, 7541–7547.
  • Schiedlmeier, B., Klump, H., et al. (2003) "High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34 + cells, but impairs lymphomyeloid differentiation", Blood, 101(5), 1759–1768.
  • Miyamoto, T., Weissman, I., et al. (2000) "AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation", Proc. Natl. Acad. Sci. USA, 97(13), 7521–7526.
  • Nishii, K, Usui, E, et al. (2003) "Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML", Leukemia, 17(4), 731 —737.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.